![1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFD111860.webp&w=3840&q=75)

1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-imidazo[4,5-c][1,5]naphthyridin-2- one
CAS:
Ref. 3D-FD111860
![1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFD111860.webp&w=3840&q=75)

Produktinformation
Name:1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-imidazo[4,5-c][1,5]naphthyridin-2- one
Marke:Biosynth
Beschreibung:Imatinib is a small molecule that inhibits the tyrosine kinase activity of the BCR-ABL protein. It is used in the treatment of chronic lymphocytic leukemia and certain types of cancers, such as skin cancer, chronic myelogenous leukemia, or gastrointestinal stromal tumors. Imatinib has been shown to inhibit the growth of tumor cells by blocking the epidermal growth factor receptor (EGFR) and blocking the activation of mitogen-activated protein kinases (MAPK). Imatinib also has anti-inflammatory effects by binding to all-trans-retinoic acid and inhibiting its conversion to retinol.
Hinweis:Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Chemische Eigenschaften
Molekulargewicht:446.5 g/mol
Formel:C24H26N6O3
Reinheit:Min. 95%